PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-46.68%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-76.32%
Negative gross profit growth while FSLR is at 0.58%. Joel Greenblatt would examine cost competitiveness or demand decline.
-143.56%
Negative EBIT growth while FSLR is at 4.17%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-132.73%
Negative operating income growth while FSLR is at 4.17%. Joel Greenblatt would press for urgent turnaround measures.
-133.34%
Negative net income growth while FSLR stands at 23.97%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-166.67%
Negative EPS growth while FSLR is at 21.08%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-166.67%
Negative diluted EPS growth while FSLR is at 22.84%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
4.01%
Share count expansion well above FSLR's 1.88%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
-0.83%
Reduced diluted shares while FSLR is at 0.59%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-216.20%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-51.35%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-19.45%
Negative 10Y revenue/share CAGR while FSLR stands at 6441.37%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-19.45%
Negative 5Y CAGR while FSLR stands at 6441.37%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
271.89%
3Y revenue/share CAGR under 50% of FSLR's 903.51%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
87.52%
OCF/share CAGR of 87.52% while FSLR is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
87.52%
OCF/share CAGR of 87.52% while FSLR is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
-484.83%
Negative 3Y OCF/share CAGR while FSLR stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
94.31%
Below 50% of FSLR's 2175.93%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
94.31%
Below 50% of FSLR's 2175.93%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-2919.88%
Negative 3Y CAGR while FSLR is 8094.11%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
214.53%
Equity/share CAGR of 214.53% while FSLR is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-48.16%
Firm’s AR is declining while FSLR shows 199.48%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
36.51%
Inventory growth well above FSLR's 8.16%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
1.54%
Asset growth well under 50% of FSLR's 8.23%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
5.44%
50-75% of FSLR's 10.65%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-2.21%
We’re deleveraging while FSLR stands at 14.96%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
594.66%
R&D growth drastically higher vs. FSLR's 5.63%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-4.82%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.